Related Experiment Videos
Single-photon emission computed tomography in distal field hypoperfusion.
1Department of Neurology, Yale University School of Medicine, New Haven, CT.
Summary
Technetium-99m hexamethylpropyleneamineoxime single-photon emission computed tomography (SPECT) may help identify stroke patients with significant large vessel disease. This imaging technique can detect distal field hypoperfusion linked to carotid stenosis.
Area of Science:
- Neurology
- Radiology
- Nuclear Medicine
Background:
- Acute cerebral ischemia requires accurate differentiation of stroke mechanisms for effective treatment.
- Large vessel disease, particularly carotid stenosis, is a common cause of ischemic stroke.
- Identifying hypoperfusion patterns can aid in diagnosing the underlying cause of stroke.
Purpose of the Study:
- To evaluate the utility of technetium-99m hexamethylpropyleneamineoxime (99mTc-HMPAO) SPECT imaging in distinguishing distal field hypoperfusion in acute cerebral ischemia.
- To correlate SPECT findings with the presence of carotid artery disease.
Main Methods:
- 24 patients with acute cerebral ischemia underwent 99mTc-HMPAO SPECT imaging.
- Two physicians independently assessed SPECT scans for criteria of distal field hypoperfusion.
- Results were correlated with findings of carotid occlusion or stenosis.
Main Results:
- 42% (10/24) of patients showed SPECT patterns indicative of probable or definite distal field hypoperfusion.
- 80% (8/10) of these patients had ipsilateral carotid occlusion or high-grade stenosis.
- Severe carotid stenosis was present in 43% (6/14) of patients with negative SPECT scans for hypoperfusion (p=0.0796).
Conclusions:
- A distal field hypoperfusion pattern on 99mTc-HMPAO SPECT may serve as an indicator of hemodynamically significant large vessel disease.
- SPECT imaging shows potential in identifying stroke patients with underlying carotid artery disease.
- This technique could assist in differentiating stroke mechanisms related to large vessel pathology.